Lysophosphatidic Acid Disrupts Junctional Integrity and Epithelial Cohesion in Ovarian Cancer Cells

被引:20
作者
Liu, Yueying [1 ,2 ]
Burkhalter, Rebecca [2 ,3 ]
Symowicz, Jaime [4 ]
Chaffin, Kim [5 ]
Ellerbroek, Shawn [5 ]
Stack, M. Sharon [1 ,2 ]
机构
[1] Univ Notre Dame, Dept Chem & Biochem, 1234 Notre Dame Ave,A200D Harper Hall, Notre Dame, IN 46557 USA
[2] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46557 USA
[3] Univ Missouri, Dept Med Pharmacol & Physiol, Sch Med, Columbia, MO 65212 USA
[4] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA
[5] Wartburg Coll, Dept Chem, Waverly, IA 50677 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1155/2012/501492
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer metastasizes via exfoliation of free-floating cells and multicellular aggregates from the primary tumor to the peritoneal cavity. A key event in EOC metastasis is disruption of cell-cell contacts via modulation of intercellular junctional components including cadherins. Ascites is rich in lysophosphatidic acid (LPA), a bioactive lipid that may promote early events in ovarian cancer dissemination. The objective of this paper was to assess the effect of LPA on E-cadherin junctional integrity. We report a loss of junctional E-cadherin in OVCAR3, OVCA429, and OVCA433 cells exposed to LPA. LPA-induced loss of Ecadherin was concentration and time dependent. LPA increased MMP-9 expression and promoted MMP-9-catalyzed E-cadherin ectodomain shedding. Blocking LPA receptor signaling inhibited MMP-9 expression and restored junctional E-cadherin staining. LPA-treated cells demonstrated a significant decrease in epithelial cohesion. Together these data support a model wherein LPA induces MMP-9 expression and MMP-9-catalyzed E-cadherin ectodomain shedding, resulting in loss of E-cadherin junctional integrity and epithelial cohesion, facilitating metastatic dissemination of ovarian cancer cells.
引用
收藏
页数:8
相关论文
共 37 条
[1]   Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm [J].
Ahmed, Nuzhat ;
Thompson, Erik W. ;
Quinn, Michael A. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (03) :581-588
[2]  
Altekruse S.F., 2010, CANCER, P1975
[3]   Plasma lysophosphatidic acid concentration and ovarian cancer [J].
Baker, DL ;
Morrison, P ;
Miller, B ;
Riely, CA ;
Tolley, B ;
Westermann, AM ;
Bonfrer, JMG ;
Bais, E ;
Moolenaar, WH ;
Tigyi, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (23) :3081-3082
[4]  
Barbolina M. V., 2009, OVARIAN CANC
[5]   STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA [J].
Benitah, SA ;
Valerón, PF ;
Rui, H ;
Lacal, JC .
MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (01) :40-53
[6]  
CHAMBERS SK, 1995, CANCER, V75, P1627, DOI 10.1002/1097-0142(19950401)75:7<1627::AID-CNCR2820750712>3.0.CO
[7]  
2-V
[8]   Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14) [J].
Covington, MD ;
Burghardt, RC ;
Parrish, AR .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (01) :F43-F51
[9]   Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells [J].
Dahl, Karen D. Cowden ;
Symowicz, Jaime ;
Ning, Yan ;
Gutierrez, Elisa ;
Fishman, David A. ;
Adley, Brian P. ;
Stack, M. Sharon ;
Hudson, Laurie G. .
CANCER RESEARCH, 2008, 68 (12) :4606-4613
[10]   Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells [J].
Do, Thuy-Vy ;
Symowicz, Jay C. ;
Berman, David M. ;
Liotta, Lance A. ;
Petricoin, Emanuel F., III ;
Stack, M. Sharon ;
Fishman, David A. .
MOLECULAR CANCER RESEARCH, 2007, 5 (02) :121-131